Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

HTSUF

Hisamitsu Pharmaceutical Co., Inc.

Healthcare · USD

Set alert

Price alert · HTSUF

All alert types
29.00 USD 0.00 0.00%
As of May 8, 2026
29.00 Day range 29.00
28.94 52-week range 32.30
YTD
0.00%
1 year
-10.22%
Open
29.00
Prev close
29.00
Mkt cap
2.04B
Vol
100
Avg vol
48
EPS
1.76
P/E
22.44
Div yield
0.00%
More statistics
Low
29.00
High
29.00
Beta
0.29
Dividend
0.824
Earnings
Jul 9, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for HTSUF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

4.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 16.8×
FY 2017: 26.3×FY 2018: 26.5×FY 2019: 24.6×FY 2020: 18.3×FY 2021: 39.7×FY 2022: 33.9×FY 2023: 28.3×FY 2024: 21.4×FY 2025: 12.5×FY 2026: 16.8×
FY 2017 5y median 21.4× FY 2026
P/S 2.0×
FY 2017: 3.7×FY 2018: 3.4×FY 2019: 3.3×FY 2020: 2.4×FY 2021: 3.2×FY 2022: 2.7×FY 2023: 2.6×FY 2024: 2.1×FY 2025: 1.7×FY 2026: 2.0×
FY 2017 5y median 2.1× FY 2026
P/B 1.1×
FY 2017: 2.4×FY 2018: 2.1×FY 2019: 1.9×FY 2020: 1.4×FY 2021: 1.5×FY 2022: 1.3×FY 2023: 1.3×FY 2024: 1.1×FY 2025: 1.0×FY 2026: 1.1×
FY 2017 5y median 1.1× FY 2026
P/FCF 33.9×
FY 2017: 32.1×FY 2018: 18.7×FY 2019: 39.0×FY 2020: 14.4×FY 2021: 193×FY 2022: 21.8×FY 2023: 69.0×FY 2024: 58.0×FY 2025: 54.6×FY 2026: 33.9×
FY 2017 5y median 54.6× FY 2026
EV/EBITDA 8.6×
FY 2017: 13.6×FY 2018: 12.1×FY 2019: 11.6×FY 2020: 7.8×FY 2021: 17.2×FY 2022: 11.6×FY 2023: 12.8×FY 2024: 7.7×FY 2025: 4.6×FY 2026: 8.6×
FY 2017 5y median 8.6× FY 2026
EV/Sales 1.3×
FY 2017: 3.1×FY 2018: 2.6×FY 2019: 2.5×FY 2020: 1.7×FY 2021: 2.2×FY 2022: 1.7×FY 2023: 1.7×FY 2024: 1.3×FY 2025: 1.0×FY 2026: 1.3×
FY 2017 5y median 1.3× FY 2026
FCF Yield 2.9%
FY 2017: 3.1%FY 2018: 5.4%FY 2019: 2.6%FY 2020: 6.9%FY 2021: 0.5%FY 2022: 4.6%FY 2023: 1.4%FY 2024: 1.7%FY 2025: 1.8%FY 2026: 2.9%
FY 2017 5y median 1.8% FY 2026

Profitability

Gross Margin 59.0%
FY 2017: 63.6%FY 2018: 62.3%FY 2019: 61.8%FY 2020: 62.1%FY 2021: 60.4%FY 2022: 58.3%FY 2023: 56.7%FY 2024: 55.7%FY 2025: 58.5%FY 2026: 59.0%
FY 2017 5y median 58.3% FY 2026
Operating Margin 11.0%
FY 2017: 18.0%FY 2018: 17.8%FY 2019: 15.5%FY 2020: 16.1%FY 2021: 9.3%FY 2022: 7.8%FY 2023: 9.0%FY 2024: 9.3%FY 2025: 12.1%FY 2026: 11.0%
FY 2017 5y median 9.3% FY 2026
Net Margin 11.8%
FY 2017: 14.0%FY 2018: 12.9%FY 2019: 13.4%FY 2020: 13.3%FY 2021: 8.1%FY 2022: 8.0%FY 2023: 9.1%FY 2024: 9.9%FY 2025: 13.9%FY 2026: 11.8%
FY 2017 5y median 9.9% FY 2026
ROE 6.6%
FY 2017: 8.9%FY 2018: 7.8%FY 2019: 7.8%FY 2020: 7.5%FY 2021: 3.7%FY 2022: 3.8%FY 2023: 4.6%FY 2024: 5.3%FY 2025: 7.9%FY 2026: 6.6%
FY 2017 5y median 5.3% FY 2026
ROIC 4.7%
FY 2017: 7.3%FY 2018: 6.9%FY 2019: 6.3%FY 2020: 6.1%FY 2021: 3.0%FY 2022: 2.6%FY 2023: 3.2%FY 2024: 3.5%FY 2025: 4.9%FY 2026: 4.7%
FY 2017 5y median 3.5% FY 2026
ROA 5.2%
FY 2017: 7.3%FY 2018: 6.4%FY 2019: 6.5%FY 2020: 6.1%FY 2021: 3.1%FY 2022: 3.2%FY 2023: 3.7%FY 2024: 4.2%FY 2025: 6.3%FY 2026: 5.2%
FY 2017 5y median 4.2% FY 2026

Growth (YoY)

Revenue 4.8%
FY 2017: -9.8%FY 2018: 1.3%FY 2019: -3.0%FY 2020: -1.7%FY 2021: -18.8%FY 2022: 5.0%FY 2023: 6.8%FY 2024: 10.4%FY 2025: 10.1%FY 2026: 4.8%
FY 2017 FY 2026
Operating Income -4.9%
FY 2017: -5.1%FY 2018: 0.1%FY 2019: -15.4%FY 2020: 2.0%FY 2021: -53.0%FY 2022: -12.5%FY 2023: 24.2%FY 2024: 13.5%FY 2025: 43.5%FY 2026: -4.9%
FY 2017 FY 2026
EPS (diluted) -8.8%
FY 2017: 15.5%FY 2018: -5.3%FY 2019: 0.7%FY 2020: -1.1%FY 2021: -50.2%FY 2022: 5.1%FY 2023: 24.4%FY 2024: 22.7%FY 2025: 62.7%FY 2026: -8.8%
FY 2017 FY 2026
Free Cash Flow 90.5%
FY 2017: -35.2%FY 2018: 62.2%FY 2019: -55.3%FY 2020: 95.5%FY 2021: -92.0%FY 2022: 689.4%FY 2023: -67.9%FY 2024: 6.9%FY 2025: -3.1%FY 2026: 90.5%
FY 2017 FY 2026

Financial Health

Current Ratio 4.1×
FY 2017: 5.3×FY 2018: 5.4×FY 2019: 6.4×FY 2020: 5.1×FY 2021: 6.6×FY 2022: 6.2×FY 2023: 4.7×FY 2024: 4.2×FY 2025: 4.3×FY 2026: 4.1×
FY 2017 5y median 4.3× FY 2026
Quick Ratio 3.6×
FY 2017: 4.8×FY 2018: 5.0×FY 2019: 5.9×FY 2020: 4.7×FY 2021: 6.0×FY 2022: 5.7×FY 2023: 4.2×FY 2024: 3.8×FY 2025: 3.8×FY 2026: 3.6×
FY 2017 5y median 3.8× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -4.3×
FY 2017: -2.3×FY 2018: -3.6×FY 2019: -3.4×FY 2020: -3.5×FY 2021: -7.6×FY 2022: -7.3×FY 2023: -7.2×FY 2024: -4.5×FY 2025: -3.2×FY 2026: -4.3×
FY 2017 5y median -4.5× FY 2026
Interest Coverage 853×
FY 2017: 675×FY 2018: 823×FY 2019: 1173×FY 2020: 1196×FY 2021: 1067×FY 2022: 467×FY 2023: 773×FY 2024: 732×FY 2025: 822×FY 2026: 853×
FY 2017 5y median 773× FY 2026

Dividends

Dividend Yield 2.4%
FY 2017: 1.3%FY 2018: 1.4%FY 2019: 1.5%FY 2020: 2.0%FY 2021: 1.9%FY 2022: 2.1%FY 2023: 2.0%FY 2024: 2.2%FY 2025: 2.4%FY 2026: 2.4%
FY 2017 5y median 2.2% FY 2026
Payout Ratio 39.6%
FY 2017: 34.0%FY 2018: 35.9%FY 2019: 35.8%FY 2020: 36.6%FY 2021: 73.6%FY 2022: 70.8%FY 2023: 57.2%FY 2024: 47.1%FY 2025: 30.0%FY 2026: 39.6%
FY 2017 5y median 47.1% FY 2026

Annual · latest fiscal year ends 2026-02-28